Jolie Siegel

General Counsel, Neon Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 14, 2025Shares withheld for tax 2,914 shares at $3.18 of C4 Therapeutics (United States)³
Feb 14, 2025Granted 56,500 shares of C4 Therapeutics (United States)³
Feb 13, 2025Shares withheld for tax 2,135 shares at $3.20 of C4 Therapeutics (United States)³
Nov 7, 2024Shares withheld for tax 1,102 shares at $6.04 of C4 Therapeutics (United States)⁴
Nov 7, 2024Exercised options 3,750 shares of C4 Therapeutics (United States)⁴
Sep 16, 2024Shares withheld for tax 661 shares at $6.36 of C4 Therapeutics (United States)⁵
Sep 16, 2024Exercised options 2,250 shares of C4 Therapeutics (United States)⁵
Feb 14, 2024Granted 27,300 shares of C4 Therapeutics (United States)⁶
Feb 13, 2024Shares withheld for tax 1,735 shares at $6.53 of C4 Therapeutics (United States)⁶
Aug 30, 2023Shares withheld for tax 661 shares at $2.93 of C4 Therapeutics (United States)⁷
Aug 30, 2023Exercised options 2,250 shares of C4 Therapeutics (United States)⁷
Feb 13, 2023Granted 20,000 shares of C4 Therapeutics (United States)⁸
Jan 30, 2023Shares withheld for tax 1,301 shares at $7.78 of C4 Therapeutics (United States)⁹
Jan 30, 2023Exercised options 3,750 shares of C4 Therapeutics (United States)⁹
May 26, 2022Shares withheld for tax 1,102 shares at $7.01 of C4 Therapeutics (United States)¹⁰
May 25, 2022Exercised options 3,750 shares of C4 Therapeutics (United States)¹¹

The numbers on this page point here. Each one links to the record it came from.